Sponsored by 
Date: Tuesday 19 May 2026
Time: 16:00 - 17:00 BST
What you'll learn
By attending, you'll gain:
- A clear picture of Europe's current R&D and innovation landscape amid rising global competition and the economic forces driving this change
- Practical insight into how the proposed reforms under the EU Biotech Act may translate into real-world considerations
- A joined-up view of EU innovation policy in action, exploring how the EU Biotech Act intersects with broader initiatives such as the EU Pharma Package and Joint Clinical Assessments (JCAs)
Who should attend
This webinar is ideal for regulatory professionals seeking to understand the impact of the EU Biotech Act on regulatory strategy and innovation:
- Regulatory Affairs and Regulatory Intelligence leaders
- Heads and Directors of Regulatory Compliance
- Regulatory Policy
- Global and EU focused regulatory strategy teams
Especially relevant for teams responsible for navigating evolving EU regulatory frameworks.
Webinar host & presenters
|
Host: Michael Ward
Global head of Thought Leadership, Clarivate
As both a journalist and analyst, Mike has been writing, analysing and commenting on the life sciences industry for more than 35 years. His actionable insights support pharma, biotech, healthcare and medtech stakeholders in understanding market trends.
|
|
Presenter: Sofia Ataide
Senior Business Solution Consultant, Clarivate
Sofia Ataide holds Masters degrees in Pharmaceutical Sciences from the University of Lisbon and International Health Management from Imperial College Business School. With nearly eight years at Clarivate, Sofia has worked across Sales and Marketing under the Cortellis Brand Portfolio. In her current role as Senior Solutions Consultant, she leverages deep domain expertise to interpret complex clinical, regulatory, and strategic requirements and translate them into integrated solution packages that best support customer needs.
|
 |
Presenter: Nuala Moran
Europe Editor, BioWorld, Clarivate
Nuala Moran has been reporting on European medical biotechnology for BioWorld since 1995. This includes covering the scientific and commercial development of the sector, all aspects of EU R&D policy, and the translation, regulation and commercialisation of research. Nuala is a former Managing Editor of Science|Business, Managing Editor of Nature and Innovation Editor of the Independent on Sunday.
|
 |
Isabel De La Paz
Patient, Access & Evidence Director, Alira Health
Isabel joined Alira Health in 2022 as Associate Director in Global Market Access and Pricing, based in Barcelona. She brings over 15 years of experience in the public healthcare system, including senior roles within the Catalan Public Healthcare System, where she led expert groups in health technology assessment and drug management. Her expertise spans drug evaluation and selection, public procurement, healthcare management, policy and strategy, and stakeholder engagement. Isabel previously worked as a hospital pharmacist, with experience in product development, clinical trials, and patient engagement.
|
 |
Martin O'Kane
Regional Head RA EU Policy & Liaison, Novartis
Martin O’Kane BSc, PhD is Regional (Europe) Head of Regulatory Affairs Policy & Liaison for Novartis Pharmaceuticals. He has over 20 years regulatory experience, including 17 years working for the UK Medicines and Healthcare products Regulatory Agency (MHRA), the majority of which was in the clinical trials field, including scientific assessment of trial applications and development of policy, guidance, and legislation relevant to the UK’s exit from the EU and the UK response to COVID-19. Martin is vice-chair of the European Federation of Pharmaceutical Industries Associations (EFPIA) Clinical Research Excellence Group. He holds a degree in Pharmacy from University of Aston, UK and a PhD in neuropharmacology from University of Glasgow, UK.
|
Pricing
| Standard webinar registration fees |
| Webinar Registration Type |
Price (GBP) |
Standard Price
TOPRA Member |
FREE |
Standard Price
Non-member |
FREE |
Invest in your expertise this year and save with TOPRA membership
Advance your regulatory knowledge and broaden your professional expertise while making your development budget go further.
Not yet a TOPRA member? Join today and benefit from ongoing savings that make membership a smart investment in your long-term growth. As a member, you’ll gain more than just discounts: you’ll access exclusive learning opportunities, expert insights, and a network of professionals shaping the future of regulatory affairs. Whether you take one course or all three, TOPRA membership helps you gain more from your development while spending less.
Join today